|
|
|
Insider
Information: |
Fuchs Henry J |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
222,228 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,063,061 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
222,228 |
|
|
Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2021-03-16 |
4 |
D |
$77.21 |
$174,417 |
D/D |
(2,259) |
108,596 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-05-01 |
4 |
AS |
$34.99 |
$174,950 |
D/D |
(5,000) |
30,018 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-06-01 |
4 |
AS |
$35.02 |
$175,078 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-12 |
4/A |
D |
$59.30 |
$177,959 |
D/D |
(3,001) |
64,849 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-06-04 |
4 |
D |
$92.07 |
$178,063 |
D/D |
(1,934) |
155,167 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2022-03-16 |
4 |
D |
$80.72 |
$182,346 |
D/D |
(2,259) |
143,753 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$183,240 |
D/D |
(2,036) |
113,878 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-06-02 |
4 |
D |
$90.72 |
$184,706 |
D/D |
(2,036) |
136,422 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-11-01 |
4 |
AS |
$37.08 |
$185,384 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-05-15 |
4 |
D |
$91.50 |
$186,294 |
D/D |
(2,036) |
138,458 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-09-04 |
4 |
AS |
$37.76 |
$188,791 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2015-05-12 |
4 |
D |
$121.09 |
$189,627 |
D/D |
(1,566) |
82,080 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2021-03-22 |
4 |
D |
$78.52 |
$192,688 |
D/D |
(2,454) |
106,142 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-08-01 |
4 |
AS |
$38.63 |
$193,145 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-10-01 |
4 |
AS |
$39.75 |
$198,760 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-09 |
4 |
S |
$57.91 |
$201,474 |
D/D |
(3,479) |
67,850 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-05-12 |
4 |
D |
$67.68 |
$203,108 |
D/D |
(3,001) |
39,373 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-05-08 |
4 |
D |
$65.32 |
$204,517 |
D/D |
(3,131) |
42,374 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-08-10 |
4 |
OE |
$20.54 |
$205,400 |
D/D |
10,000 |
12,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-12-15 |
4 |
OE |
$20.54 |
$205,400 |
D/D |
10,000 |
12,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-03-02 |
4 |
D |
$79.86 |
$205,719 |
D/D |
(2,576) |
151,309 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-04 |
4 |
AS |
$95.00 |
$208,620 |
D/D |
(2,196) |
142,504 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-10 |
4 |
OE |
$21.01 |
$210,100 |
D/D |
10,000 |
28,334 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-02-03 |
4 |
OE |
$21.51 |
$215,100 |
D/D |
10,000 |
52,350 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-08-05 |
4 |
OE |
$21.51 |
$215,100 |
D/D |
10,000 |
86,550 |
0 |
- |
|
294 Records found
|
|
Page 8 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|